Publications by authors named "Giulia Ruzzante"

Claim this Profile
D
Discovery of the TLR7/8 Antagonist MHV370 for Treatment of Systemic Autoimmune Diseases.
Phil Alper, Claudia Betschart, Cédric André, Thomas Boulay, Dai Cheng, Giulia Ruzzante

ACS Med Chem Lett· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical characterization of the Toll-like receptor 7/8 antagonist MHV370 for lupus therapy.
Stuart Hawtin, Cédric André, Géraldine Collignon-Zipfel, Simone Appenzeller, Bettina Bannert, Giulia Ruzzante

Cell Rep Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonhematopoietic IRAK1 drives arthritis via neutrophil chemoattractants.
Thomas Hoyler, Bettina Bannert, Cédric André, Damian Beck, Thomas Boulay, Giulia Ruzzante

JCI Insight· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Based Optimization of a Fragment-like TLR8 Binding Screening Hit to an Efficacious TLR7/8 Antagonist.
Claudia Betschart, Michael Faller, Florence Zink, René Hemmig, Jutta Blank, Giulia Ruzzante

ACS Med Chem Lett· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice.
Kirsten D Mertz, Lukas F Mager, Marie-Hélène Wasmer, Thore Thiesler, Viktor H Koelzer, Giulia Ruzzante

Oncoimmunology· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis.
Annette Ives, Catherine Ronet, Florence Prevel, Giulia Ruzzante, Silvia Fuertes-Marraco

Science· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis